TYK MEDICINES-B(02410)

33.000+1.700+5.43%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- TYK Medicines, Inc's (HKG:2410) largest shareholders are private companies who were rewarded as market cap surged HK$3.3b last week
  Simply Wall St. · 02-19
  TYK Medicines, Inc's (HKG:2410) largest shareholders are private companies who were rewarded as market cap surged HK$3.3b last week
- TYK Medicines Concludes H-Share Full Circulation
  MT Newswires Live · 02-18
  TYK Medicines Concludes H-Share Full Circulation
- TYK Medicines Secures Hong Kong Exchange Listing Approval for Over 173.6 Million H Shares
  MT Newswires Live · 02-11
  TYK Medicines Secures Hong Kong Exchange Listing Approval for Over 173.6 Million H Shares
Company Profile
Company Name
TYK MEDICINES-B
Market
SEHK
Establishment Date
- -
Employees
- -
Office Location
- -
Website
- -
Zip Code
- -
Phone
- -
Fax
- -
Introduction
TYK Medicines Inc is a China-based company mainly engaged in developing and commercializing pharmaceutical products. The Company is primarily focused on small molecule drug development, and its main products include TY-9591, TY-302 and TY-2136. TY-9591 is a third-generation EGFR-TKI with antitumor effects on EGFR mutations. TY-302 is a potent, selective oral CDK4/6 inhibitor developed for the treatment of advanced solid tumors, including breast cancer and prostate cancer. TY-2136b is an internally developed, oral ROS1/NTRK inhibitor for the treatment of solid tumors.

1D
5D
Day
Week
Month

High

33.000

Open

32.950

Volume%

0.84

Low

29.550

Close

31.300

T/O Rate

0.42%

抱歉，当前请求异常(-1)

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"pagemeta":{"title":"TYK MEDICINES-B(02410),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TYK MEDICINES-B(02410) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TYK MEDICINES-B,02410,TYK MEDICINES-B股票,TYK MEDICINES-B股票老虎,TYK MEDICINES-B股票老虎国际,TYK MEDICINES-B行情,TYK MEDICINES-B股票行情,TYK MEDICINES-B股价,TYK MEDICINES-B股市,TYK MEDICINES-B股票价格,TYK MEDICINES-B股票交易,TYK MEDICINES-B股票购买,TYK MEDICINES-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TYK MEDICINES-B(02410),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TYK MEDICINES-B(02410) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"news","symbol":"02410","data":{"stockData":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"TYK MEDICINES-B","latestPrice":33,"timestamp":1742976535016,"preClose":31.3,"halted":0,"volume":1522500,"delay":0,"floatShares":366000000,"shares":371000000,"eps":-1.415287327252226,"marketStatus":"Closed","change":1.7,"latestTime":"03-26 16:08:55","open":32.95,"high":33,"low":29.55,"amount":47238675,"amplitude":0.110224,"askPrice":33,"askSize":2500,"bidPrice":32.6,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-1.4996801362416892,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1743039000000},"marketStatusCode":5,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":31.3,"openAndCloseTimeList":[[1742952600000,1742961600000],[1742965200000,1742976000000]],"volumeRatio":0.842277,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":{"listData":[{"id":"2512462559","title":"TYK Medicines, Inc's (HKG:2410) largest shareholders are private companies who were rewarded as market cap surged HK$3.3b last week","url":"https://stock-news.laohu8.com/highlight/detail?id=2512462559","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512462559?lang=en_us&edition=full_marsco","pubTime":"2025-02-20 07:42","pubTimestamp":1740008534,"startTime":"0","endTime":"0","summary":"Key Insights TYK Medicines' significant private companies ownership suggests that the key decisions are influenced by...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2410/tyk-medicines-shares/news/tyk-medicines-incs-hkg2410-largest-shareholders-are-private","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","02410","MDCO"],"gpt_icon":0},{"id":"2512132033","title":"TYK Medicines Concludes H-Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2512132033","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512132033?lang=en_us&edition=full_marsco","pubTime":"2025-02-18 18:01","pubTimestamp":1739872897,"startTime":"0","endTime":"0","summary":"TYK Medicines  completed the conversion of 173,641,645 unlisted shares into Hong Kong shares on Tuesday, a same-day bourse filing said.The listing of the converted H shares will begin Wednesday, Feb. 19.The pharmaceutical products company applied for the H share full circulation in September 2024.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02410","BK1161","MDCO"],"gpt_icon":0},{"id":"2510411827","title":"TYK Medicines Secures Hong Kong Exchange Listing Approval for Over 173.6 Million H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2510411827","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510411827?lang=en_us&edition=full_marsco","pubTime":"2025-02-11 14:35","pubTimestamp":1739255748,"startTime":"0","endTime":"0","summary":"TYK Medicines  said the Listing Committee of the Stock Exchange of Hong Kong approved the listing of the company's 173,641,645 H shares on the exchange on Monday, a same-day bourse filing said.The said H shares are to be converted from the same number of unlisted shares held by 25 company shareholders. The exchange also granted permission to deal in the converted H shares to the company.The company had applied to the Exchange for the conversion and listing of the said shares on Sept. 13, 2024.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","MDCO","02410"],"gpt_icon":0}],"currentPage":1,"bottom":true},"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":{"stockEarnings":[{"period":"1week","weight":0.1507},{"period":"1month","weight":0.0097},{"period":"3month","weight":-0.436},{"period":"6month","weight":0.0195},{"period":"1year","weight":1.5868},{"period":"ytd","weight":-0.3362}],"compareEarnings":[{"period":"1week","weight":-0.0564},{"period":"1month","weight":-0.0057},{"period":"3month","weight":0.1615},{"period":"6month","weight":0.1716},{"period":"1year","weight":0.4171},{"period":"ytd","weight":0.1637}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"TYK Medicines Inc is a China-based company mainly engaged in developing and commercializing pharmaceutical products. The Company is primarily focused on small molecule drug development, and its main products include TY-9591, TY-302 and TY-2136. TY-9591 is a third-generation EGFR-TKI with antitumor effects on EGFR mutations. TY-302 is a potent, selective oral CDK4/6 inhibitor developed for the treatment of advanced solid tumors, including breast cancer and prostate cancer. TY-2136b is an internally developed, oral ROS1/NTRK inhibitor for the treatment of solid tumors.","exchange":"SEHK","name":"TYK MEDICINES-B","nameEN":"TYK MEDICINES-B"},"aProfile":null}}}